PMC7336923 1. Environmental Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) from Medical Equipment in Long-Term Care Facilities undergoing COVID-19 Outbreaks.
32645474
PMC7336929 2. Disinfection of N95 masks artificially contaminated with SARS-CoV-2 and ESKAPE bacteria using hydrogen peroxide plasma: impact on the reutilization of disposable devices.
32645473
PMC7212949 3. A Comprehensive Review of Manifestations of Novel Coronaviruses in the Context of Deadly COVID-19 Global Pandemic.
32620220
PMC7326424 4. Supraglottic airways in the management of COVID-19 patients.
32619530
5. Enhancing colorimetric loop-mediated isothermal amplification speed and sensitivity with guanidine chloride.
32635743
PMC7337881 6. Is continuous positive airway pressure (CPAP) a new standard of care for type 1 respiratory failure in COVID-19 patients? A retrospective observational study of a dedicated COVID-19 CPAP service.
32624495
PMC7337887 7. Improved survival following ward-based non-invasive pressure support for severe hypoxia in a cohort of frail patients with COVID-19: retrospective analysis from a UK teaching hospital.
32624494
PMC7347253 8. Should we use angiotensin II infusion in COVID-19-associated vasoplegic shock?
32646518
PMC7344041 9. Classification of COVID-19 in intensive care patients.
32646506
PMC7347264 10. Impact of initial respiratory compliance in ventilated patients with acute respiratory distress syndrome related to COVID-19.
32646470
PMC7347263 11. Angiotensin II treatment in COVID-19 patients: more risk than benefit? A single-center experience.
32646469
PMC7347254 12. Transpulmonary pressure in SARS-CoV-2-associated acute respiratory distress syndrome: a single-center observational study.
32646456
PMC7330272 13. Acute complications and mortality in hospitalized patients with coronavirus disease 2019: a systematic review and meta-analysis.
32616077
PMC7338276 14. Development and validation of the HNC-LL score for predicting the severity of coronavirus disease 2019.
32645614
15. Effectiveness of Cloth Masks for Protection Against Severe Acute Respiratory Syndrome Coronavirus 2.
32639930
16. High Proportion of Asymptomatic SARS-CoV-2 Infections in 9 Long-Term Care Facilities, Pasadena, California, USA, April 2020.
32614768
PMC7338094 17. Transcatheter drug delivery through bronchial artery for COVID-19: is it fiction or could it come true?
32632766
PMC7338402 18. Rationale and significance of patient selection in awake prone positioning for COVID-19 pneumonia.
32631837
PMC7331647 19. COVID-19 phenotypes: leading or misleading?
32616591
PMC7257617 20. What do differences in case fatality ratios between children and adults tell us about COVID-19?
32471937
PMC7241110 21. What do differences in case fatality ratios between children and adults tell us about COVID-19?
32430425
PMC7340745 22. COVID-19 in Children: Clinical Approach and Management- Correspondence.
32638337
PMC7323672 23. Predicting Severe Outcomes in COVID-19.
32615256
24. ACE2 as a Therapeutic Target for COVID-19; its Role in Infectious Processes and Regulation by Modulators of the RAAS System.
32635289
PMC7326402 25. Clinical recurrences of COVID-19 symptoms after recovery: viral relapse, reinfection or inflammatory rebound?
32619697
PMC7338016 26. COVID-19-associated acute respiratory distress syndrome: is a different approach to management warranted?
32645311
27. Middle East Respiratory Syndrome Coronavirus (MERS-CoV): State of the Science.
32630780
PMC7333574 28. Increasing Temperature and Relative Humidity Accelerates Inactivation of SARS-CoV-2 on Surfaces.
32611701
PMC7328300 29. Grundlagen der Replikation und der Immunologie von SARS-CoV-2.
32613257
PMC7340139 30. Clinical Features of Critical Coronavirus Disease 2019 in Children.
32639466
PMC7336751 31. High Incidence of Barotrauma in Patients with COVID-19 Infection on Invasive Mechanical Ventilation.
32614258
PMC7332943 32. Non-invasive CPAP in mild and moderate ARDS secondary to SARS-CoV-2.
32629100
PMC7341708 33. The newly emerged COVID-19 disease: a systemic review.
32641059
PMC7332739 34. Recommendations for extracorporeal membrane oxygenation (ECMO) in COVID-19 patients : Consensus paper of the Medical University of Vienna.
32621065
{{tp|p=32645474|t=2020. Environmental Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) from Medical Equipment in Long-Term Care Facilities undergoing COVID-19 Outbreaks.|pdf=|usr=}}
{{tp|p=32645473|t=2020. Disinfection of N95 masks artificially contaminated with SARS-CoV-2 and ESKAPE bacteria using hydrogen peroxide plasma: impact on the reutilization of disposable devices.|pdf=|usr=}}
{{tp|p=32620220|t=2020. A Comprehensive Review of Manifestations of Novel Coronaviruses in the Context of Deadly COVID-19 Global Pandemic.|pdf=|usr=}}
{{tp|p=32619530|t=2020. Supraglottic airways in the management of COVID-19 patients.|pdf=|usr=}}
{{tp|p=32635743|t=2020. Enhancing colorimetric loop-mediated isothermal amplification speed and sensitivity with guanidine chloride.|pdf=|usr=}}
{{tp|p=32624495|t=2020. Is continuous positive airway pressure (CPAP) a new standard of care for type 1 respiratory failure in COVID-19 patients? A retrospective observational study of a dedicated COVID-19 CPAP service.|pdf=|usr=}}
{{tp|p=32624494|t=2020. Improved survival following ward-based non-invasive pressure support for severe hypoxia in a cohort of frail patients with COVID-19: retrospective analysis from a UK teaching hospital.|pdf=|usr=}}
{{tp|p=32646518|t=2020. Should we use angiotensin II infusion in COVID-19-associated vasoplegic shock?|pdf=|usr=}}
{{tp|p=32646506|t=2020. Classification of COVID-19 in intensive care patients.|pdf=|usr=}}
{{tp|p=32646470|t=2020. Impact of initial respiratory compliance in ventilated patients with acute respiratory distress syndrome related to COVID-19.|pdf=|usr=}}
{{tp|p=32646469|t=2020. Angiotensin II treatment in COVID-19 patients: more risk than benefit? A single-center experience.|pdf=|usr=}}
{{tp|p=32646456|t=2020. Transpulmonary pressure in SARS-CoV-2-associated acute respiratory distress syndrome: a single-center observational study.|pdf=|usr=}}
{{tp|p=32616077|t=2020. Acute complications and mortality in hospitalized patients with coronavirus disease 2019: a systematic review and meta-analysis.|pdf=|usr=}}
{{tp|p=32645614|t=2020. Development and validation of the HNC-LL score for predicting the severity of coronavirus disease 2019.|pdf=|usr=}}
{{tp|p=32639930|t=2020. Effectiveness of Cloth Masks for Protection Against Severe Acute Respiratory Syndrome Coronavirus 2.|pdf=|usr=}}
{{tp|p=32614768|t=2020. High Proportion of Asymptomatic SARS-CoV-2 Infections in 9 Long-Term Care Facilities, Pasadena, California, USA, April 2020.|pdf=|usr=}}
{{tp|p=32632766|t=2020. Transcatheter drug delivery through bronchial artery for COVID-19: is it fiction or could it come true?|pdf=|usr=}}
{{tp|p=32631837|t=2020. Rationale and significance of patient selection in awake prone positioning for COVID-19 pneumonia.|pdf=|usr=}}
{{tp|p=32616591|t=2020. COVID-19 phenotypes: leading or misleading?|pdf=|usr=}}
{{tp|p=32471937|t=2020. What do differences in case fatality ratios between children and adults tell us about COVID-19?|pdf=|usr=}}
{{tp|p=32430425|t=2020. What do differences in case fatality ratios between children and adults tell us about COVID-19?|pdf=|usr=}}
{{tp|p=32638337|t=2020. COVID-19 in Children: Clinical Approach and Management- Correspondence.|pdf=|usr=}}
{{tp|p=32615256|t=2020. Predicting Severe Outcomes in COVID-19.|pdf=|usr=}}
{{tp|p=32635289|t=2020. ACE2 as a Therapeutic Target for COVID-19; its Role in Infectious Processes and Regulation by Modulators of the RAAS System.|pdf=|usr=}}
{{tp|p=32619697|t=2020. Clinical recurrences of COVID-19 symptoms after recovery: viral relapse, reinfection or inflammatory rebound?|pdf=|usr=}}
{{tp|p=32645311|t=2020. COVID-19-associated acute respiratory distress syndrome: is a different approach to management warranted?|pdf=|usr=}}
{{tp|p=32630780|t=2020. Middle East Respiratory Syndrome Coronavirus (MERS-CoV): State of the Science.|pdf=|usr=}}
{{tp|p=32611701|t=2020. Increasing Temperature and Relative Humidity Accelerates Inactivation of SARS-CoV-2 on Surfaces.|pdf=|usr=}}
{{tp|p=32613257|t=2020. Grundlagen der Replikation und der Immunologie von SARS-CoV-2.|pdf=|usr=}}
{{tp|p=32639466|t=2020. Clinical Features of Critical Coronavirus Disease 2019 in Children.|pdf=|usr=}}
{{tp|p=32614258|t=2020. High Incidence of Barotrauma in Patients with COVID-19 Infection on Invasive Mechanical Ventilation.|pdf=|usr=}}
{{tp|p=32629100|t=2020. Non-invasive CPAP in mild and moderate ARDS secondary to SARS-CoV-2.|pdf=|usr=}}
{{tp|p=32641059|t=2020. The newly emerged COVID-19 disease: a systemic review.|pdf=|usr=}}
{{tp|p=32621065|t=2020. Recommendations for extracorporeal membrane oxygenation (ECMO) in COVID-19 patients : Consensus paper of the Medical University of Vienna.|pdf=|usr=}}
35. COVID-19 in Italian pediatric patients: the experience of a tertiary children's hospital.
32640088
36. Review of Burden, Clinical Definitions, and Management of COVID-19 Cases.
32618260
37. Differential Ventilation Using Flow Control Valves as a Potential Bridge to Full Ventilatory Support during the COVID-19 Crisis: From Bench to Bedside.
32639236
38. Critical paediatric COVID-19: varied presentations but good outcomes.
32601086
39. COVID-19: children on the front line.
32601085
40. The Potential of Various Nanotechnologies for Coronavirus Diagnosis/Treatment Highlighted through a Literature Analysis.
32639742
41. Against the odds: unlikely COVID-19 recovery.
32620682
42. CoVID-19 insights from transfusion medicine.
32640485
43. Blood Component Use in Critical Care in Patients with COVID-19 Infection: A Single Centre Experience.
32640484
44. Could it be COVID-19? Atypical presentations in a pandemic.
32611881
45. Overview of Covid-19 regarding the cardiovascular situation in the light of current reports.
32611305
46. Personalized therapy approach for hospitalized patients with COVID-19.
32649747
47. Development and Validation of a Nomogram for Assessing Survival in Patients with COVID-19 Pneumonia.
32649738
48. The practical challenges of making clinical use of the quantitative value for SARS-CoV-2 viral load across several dynamics.
32645717
49. COVID-19 Epidemic: Clinical Characteristics of Patients in Pediatric Isolation Ward.
32646234
50. Young Children Presenting With Fever and Rash in the Midst of SARS-CoV-2 Outbreak in New York.
32633553
51. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 disease.
32633856
52. The COVID-19 pandemic.
32645276
53. The optimal diagnostic methods for COVID-19.
32621728
54. Potential drug-drug interactions associated with drugs currently proposed for COVID-19 treatment in patients receiving other treatments.
32615022
55. Initial Observations of COVID-19 in US Children.
32636210
56. Interventions for healthcare professionals taking care of COVID-19 patients (beyond vaccines). A systematic review.
32616087
57. Has Venoarterial ECMO Been Underutilized in COVID-19 Patients?
32634058
58. Protecting prone positioned patients from facial pressure ulcers using prophylactic dressings: A timely biomechanical analysis in the context of the COVID-19 pandemic.
32618418
59. Classification of the COVID-19 infected patients using DenseNet201 based deep transfer learning.
32619398
60. Clinical Frailty Scale for risk stratification in patients with SARS-CoV-2 infection.
32641351
61. Early-stage predictors of the acute phase duration in uncomplicated COVID-19 pneumonia.
32644215
62. Microstructure, pathophysiology and potential therapeutics of COVID-19: A comprehensive review.
32617987
63. Extra-pulmonary complications of COVID-19: a multi-system disease?
32648973
64. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review.
32648899
65. Audio Interview: Acute Lung Injury in Covid-19.
32640146
66. SARS, MERS, COVID-19: Clinical Manifestations and Organ-System Complications: A Mini Review.
32633327
67. Duration of Respiratory and Gastrointestinal Viral Shedding in Children With SARS-CoV-2: A Systematic Review and Synthesis of Data.
32618932
68. COVID-19 PICU guidelines: for high- and limited-resource settings.
32634818
69. COVID-19: Precautions with children in home mechanical ventilation.
32615580
70. Veno-venous extracorporeal membrane oxygenation for COVID-19-associated pediatric acute respiratory distress syndrome.
32643551
71. END-TIDAL-TO-ARTERIAL PCO2 RATIO AS SIGNIFIER FOR PHYSIOLOGIC DEAD-SPACE RATIO AND OXYGENATION DYSFUNCTION IN ACUTE RESPIRATORY DISTRESS SYNDROME.
32636278
72. Current pharmacological modalities for management of novel coronavirus disease 2019 (COVID-19) and the rationale for their utilization: A review.
32644275
{{tp|p=32640088|t=2020. COVID-19 in Italian pediatric patients: the experience of a tertiary children's hospital.|pdf=|usr=}}
{{tp|p=32618260|t=2020. Review of Burden, Clinical Definitions, and Management of COVID-19 Cases.|pdf=|usr=}}
{{tp|p=32639236|t=2020. Differential Ventilation Using Flow Control Valves as a Potential Bridge to Full Ventilatory Support during the COVID-19 Crisis: From Bench to Bedside.|pdf=|usr=}}
{{tp|p=32601086|t=2020. Critical paediatric COVID-19: varied presentations but good outcomes.|pdf=|usr=}}
{{tp|p=32601085|t=2020. COVID-19: children on the front line.|pdf=|usr=}}
{{tp|p=32639742|t=2020. The Potential of Various Nanotechnologies for Coronavirus Diagnosis/Treatment Highlighted through a Literature Analysis.|pdf=|usr=}}
{{tp|p=32620682|t=2020. Against the odds: unlikely COVID-19 recovery.|pdf=|usr=}}
{{tp|p=32640485|t=2020. CoVID-19 insights from transfusion medicine.|pdf=|usr=}}
{{tp|p=32640484|t=2020. Blood Component Use in Critical Care in Patients with COVID-19 Infection: A Single Centre Experience.|pdf=|usr=}}
{{tp|p=32611881|t=2020. Could it be COVID-19? Atypical presentations in a pandemic.|pdf=|usr=}}
{{tp|p=32611305|t=2020. Overview of Covid-19 regarding the cardiovascular situation in the light of current reports.|pdf=|usr=}}
{{tp|p=32649747|t=2020. Personalized therapy approach for hospitalized patients with COVID-19.|pdf=|usr=}}
{{tp|p=32649738|t=2020. Development and Validation of a Nomogram for Assessing Survival in Patients with COVID-19 Pneumonia.|pdf=|usr=}}
{{tp|p=32645717|t=2020. The practical challenges of making clinical use of the quantitative value for SARS-CoV-2 viral load across several dynamics.|pdf=|usr=}}
{{tp|p=32646234|t=2020. COVID-19 Epidemic: Clinical Characteristics of Patients in Pediatric Isolation Ward.|pdf=|usr=}}
{{tp|p=32633553|t=2020. Young Children Presenting With Fever and Rash in the Midst of SARS-CoV-2 Outbreak in New York.|pdf=|usr=}}
{{tp|p=32633856|t=2020. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 disease.|pdf=|usr=}}
{{tp|p=32645276|t=2020. The COVID-19 pandemic.|pdf=|usr=}}
{{tp|p=32621728|t=2020. The optimal diagnostic methods for COVID-19.|pdf=|usr=}}
{{tp|p=32615022|t=2020. Potential drug-drug interactions associated with drugs currently proposed for COVID-19 treatment in patients receiving other treatments.|pdf=|usr=}}
{{tp|p=32636210|t=2020. Initial Observations of COVID-19 in US Children.|pdf=|usr=}}
{{tp|p=32616087|t=2020. Interventions for healthcare professionals taking care of COVID-19 patients (beyond vaccines). A systematic review.|pdf=|usr=}}
{{tp|p=32634058|t=2020. Has Venoarterial ECMO Been Underutilized in COVID-19 Patients?|pdf=|usr=}}
{{tp|p=32618418|t=2020. Protecting prone positioned patients from facial pressure ulcers using prophylactic dressings: A timely biomechanical analysis in the context of the COVID-19 pandemic.|pdf=|usr=}}
{{tp|p=32619398|t=2020. Classification of the COVID-19 infected patients using DenseNet201 based deep transfer learning.|pdf=|usr=}}
{{tp|p=32641351|t=2020. Clinical Frailty Scale for risk stratification in patients with SARS-CoV-2 infection.|pdf=|usr=}}
{{tp|p=32644215|t=2020. Early-stage predictors of the acute phase duration in uncomplicated COVID-19 pneumonia.|pdf=|usr=}}
{{tp|p=32617987|t=2020. Microstructure, pathophysiology and potential therapeutics of COVID-19: A comprehensive review.|pdf=|usr=}}
{{tp|p=32648973|t=2020. Extra-pulmonary complications of COVID-19: a multi-system disease?|pdf=|usr=}}
{{tp|p=32648899|t=2020. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review.|pdf=|usr=}}
{{tp|p=32640146|t=2020. Audio Interview: Acute Lung Injury in Covid-19.|pdf=|usr=}}
{{tp|p=32633327|t=2020. SARS, MERS, COVID-19: Clinical Manifestations and Organ-System Complications: A Mini Review.|pdf=|usr=}}
{{tp|p=32618932|t=2020. Duration of Respiratory and Gastrointestinal Viral Shedding in Children With SARS-CoV-2: A Systematic Review and Synthesis of Data.|pdf=|usr=}}
{{tp|p=32634818|t=2020. COVID-19 PICU guidelines: for high- and limited-resource settings.|pdf=|usr=}}
{{tp|p=32615580|t=2020. COVID-19: Precautions with children in home mechanical ventilation.|pdf=|usr=}}
{{tp|p=32643551|t=2020. Veno-venous extracorporeal membrane oxygenation for COVID-19-associated pediatric acute respiratory distress syndrome.|pdf=|usr=}}
{{tp|p=32636278|t=2020. END-TIDAL-TO-ARTERIAL PCO2 RATIO AS SIGNIFIER FOR PHYSIOLOGIC DEAD-SPACE RATIO AND OXYGENATION DYSFUNCTION IN ACUTE RESPIRATORY DISTRESS SYNDROME.|pdf=|usr=}}
{{tp|p=32644275|t=2020. Current pharmacological modalities for management of novel coronavirus disease 2019 (COVID-19) and the rationale for their utilization: A review.|pdf=|usr=}}